Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 15, 2022 08:00 ET | Source: Vyant Bio, Inc.

Vyant Bio Reports Third Quarter 2022 Results and Provides Strategic and Business Highlights

Q3 2022 and Recent Scientific and Business Highlights Completed the sale of its vivoPharm subsidiary to Reaction Biology Corporation for $5.5 million in an upfront cash paymentDelivered...